Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 11:22, 10 July 2024 Cotto talk contribs deleted page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
• 10:06, 10 July 2024 MKraft talk contribs created page Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study (Created page with "{{Reference |Reference=Publication: Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study }} {{Study Note |Study Note=? }} =Brief summary= The study included 469 patients with different types of cancer. Randomly divided into 3 groups, one group received megestrol acetate, one group received dronabinol and one group received both drugs. After an estimated 2-3 months, there was an advanta...")
• 09:50, 10 July 2024 MKraft talk contribs created page Publication: Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study (Created page with "{{Publication |Title=Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study |Topic=Cannabinoids |Author=Jatoi, A; Windschitl, H E; Loprinzi, C L; Sloan, J A; Dakhil, S R; Mailliard, J A; Pundaleeka, S; Kardinal, C G; Fitch, T R; Krook, J E; Novotny, P J; Christensen, B |Year=2002 |Journal=Journal of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2002.20.2.567 |Authors Abstract=Purpos...")
• 14:10, 9 July 2024 JDoerfler talk contribs created page Publication: The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Publication |Title=The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial |Topic=Vitamin E |Author=Shamsaei G; Ahmadzadeh A; Mehraban N |Year=2017 |Journal=Jundishapur Journal Of Natural Pharmaceutical Products |DOI=https://doi.org/10.5812/jjnpp.65027 |Authors Abstract=Background: Chemotherapy-induced neuropathy is one of the most severe complications of cancer drug therapies causing a number of proble...")
• 14:07, 9 July 2024 JDoerfler talk contribs created page Shamsaei et al. (2017): The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Prospective |Centralized=Monocentric |Blinding=Single |Is randomized=Yes |Cross-over=No |Number of arms=2 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=70 |Analysis=ITT Analysis |Specifications on analyses=ITT not specified, but no drop-out reported. |Countries of data collectio...")
• 14:00, 9 July 2024 JDoerfler talk contribs created page Salehi et al. (2015): Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Reference |Reference=Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial }} {{Study Note}} =Brief summary= This study investigated the efficacy of vitamin E in colorectal cancer patients to alleviate chemotherapy-associated peripheral neuropathy (i.e. damage to several peripheral nerves). The intervention arm took additional vitamin E during chemotherapy and the control arm received only a placebo. The...")
• 13:50, 9 July 2024 JDoerfler talk contribs created page Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Publication |Title=Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial |Topic=Vitamin E |Author=Salehi, Z; Roayaei M |Year=2015 |Journal=International Journal of preventive Medicine |DOI=https://doi.org/10.4103/2008-7802.169021 |Authors Abstract=Background: Peripheral neuropathy is one of the most important limitations of oxaliplatin base regimen, which is the standard for the treatment of colorectal cancer. Eviden...")
• 13:09, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2010): Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection for cisplatin neuropathy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instead. The results of this study are analogous to th...")
• 13:06, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Publication |Title=Vitamin E neuroprotection for cisplatin neuropathy |Topic=Vitamin E |Author=Pace, A; Giannarelli, D; Galie, E; Savarese, A; Carpano, S; Della Giulia, M; Pozzi, A; Silvani, A; Gaviani, P; Scaioli, V; Jandolo, B; Bove, L; Cognetti, F |Year=2010 |Journal=Neurology |DOI=https://doi.org/10.1212/WNL.0b013e3181d5279e |Authors Abstract=The clinical use of platinum-based antineoplastic agents is limited by severe peripheral neurotoxicity reported in up to 90%...")
• 12:06, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Reference |Reference=Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instea...")
• 12:02, 9 July 2024 JDoerfler talk contribs created page Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Publication |Title=Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy |Topic=Vitamin E |Author=Pace, A; Savarese, A; Picardo, M; Maresca, V; Pacetti, U; Del Monte, G; Biroccio, A; Leonetti, C; Jandolo, B; Cognetti, F; Bove, L |Year=2003 |Journal=Journal of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2003.05.139 |Authors Abstract=Purpose: The aim of this study is to evaluate the neuroprotective effect of antioxidant...")
• 11:42, 9 July 2024 DDeel talk contribs moved page Publication Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients to Publication: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients without leaving a redirect
• 11:41, 9 July 2024 DDeel talk contribs created page Bairati et al. (2006): Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications o...")
• 11:40, 9 July 2024 DDeel talk contribs created page Publication Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients (Created page with "{{Publication |Title=Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients |Topic=Vitamin A (beta-carotene), Vitamin E |Author=Bairati, I; Meyer, F; Jobin, E; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Têtu, B |Year=2006 |Journal=International journal of cancer |DOI=https://doi.org/10.1002/ijc.22042 |Authors Abstract=There has been concern that long-term supplementation with highdose antioxidant vitamins, especially v...")
• 09:54, 9 July 2024 DDeel talk contribs created page Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients (Created page with "{{Reference |Reference=Publication: Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Anal...")
• 09:53, 9 July 2024 DDeel talk contribs created page Publication: Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients (Created page with "{{Publication |Title=Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients |Topic=Vitamin A (beta-carotene), Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J; Têtu, B; Harel, F; Abdous, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of clinical oncology |DOI=https://doi.org/10.1200/JCO.2005.05.514 |Authors Abstract=Purp...")
• 09:44, 9 July 2024 DDeel talk contribs moved page Bairati et al. (2005): A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients to Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients without leaving a redirect
• 09:42, 9 July 2024 DDeel talk contribs deleted page Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (content was: "{{Publication |Title=A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients |Topic=Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J. P; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Insti...", and the only contributor was "JDoerfler" (talk))
• 08:51, 9 July 2024 JDoerfler talk contribs deleted page TestPublication (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
• 08:49, 9 July 2024 JDoerfler talk contribs moved page Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. to Dale, PS without leaving a redirect
• 08:41, 9 July 2024 DDeel talk contribs created page Muecke, R (Created page with "{{Author}}")
• 08:37, 9 July 2024 DDeel talk contribs created page Lippman, SM (Created page with "{{Author}}")
• 08:27, 9 July 2024 JDoerfler talk contribs created page Test author (Created blank page)
• 07:26, 9 July 2024 JDoerfler talk contribs created page Mondal et al. (2014): Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Reference |Reference=Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy }} {{Study Note}} =Brief summary= In this study, four different arms of cancer patients were examined, all of whom received chemotherapy. During chemotherapy, one arm received additional vitamin E, one arm vitamin B12, one arm glutamine and the last arm carnitine. Components of peripheral neuro...")
• 07:22, 9 July 2024 JDoerfler talk contribs created page Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Publication |Title=Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy |Topic=Vitamin E, Carnitine, Vitamin B12 |Author=Mondal, S; Choudhury, KB; Sharma, S; Gupta, A; Dutta, S |Year=2014 |Journal=Clinical Cancer Investigation Journal |DOI=https://doi.org/10.4103/2278-0513.132113 |Authors Abstract=Context One of the major toxicities of paclitaxel is peripheral neuropathy, primar...")
• 06:28, 9 July 2024 JDoerfler talk contribs created page Mazdak et al. (2012): Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Reference |Reference=Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial }} {{Study Note}} =Brief summary= In this study, bladder cancer patients were examined with regard to the occurrence of recurrences after surgery, with half of the patients taking vitamin E daily and the other half taking nothing. There were significantly fewer recurrences in the vitamin E arm (19% vs. 36%) than in the control arm. There were no diff...")
• 06:27, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Publication |Title=Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial |Topic=Vitamin E |Author=Mazdak, H; Zia, H |Year=2012 |Journal=International Journal of Preventive Medicine |DOI=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278875/ |Authors Abstract=Background Most patients with superficial bladder cancer who undergo transurethral resection of bladder tumor show recurrence of the disease. Numerous studies have explored ways to...")
• 21:15, 8 July 2024 Lbordihn talk contribs created page Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (Created page with "{{Reference |Reference=ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy }} {{Study Note}} =Brief summary= In this study, 120 patients were randomly assigned to two groups. One group received a preparation containing zeolite, while the other group received a placebo. The occurrence and severity of peripheral neuropathy due to oxaliplatin chemothe...")
• 20:30, 8 July 2024 Lbordihn talk contribs created page Publication: ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (Created page with "{{Publication |Title=ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy |Topic=Zeolites |Author=Vitale, MG; Barbato, C; Crispo, A; Habetswallner, F; De Martino, BM; Riccardi, F; Maione, A; Eisenwagen, S; Vitale, G; Cartenì, G |Year=2020 |Journal=molecules |DOI=10.3390/molecules25102297​ |Authors Abstract=Chemotherapy-induced peripheral neuropat...")
• 13:38, 8 July 2024 Lbordihn talk contribs created page Vitale et al.: ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (Created page with "{{Author}}")
• 13:32, 8 July 2024 Lbordihn talk contribs created page Vitale, MG; Barbato, C; Crispo, A; Habetswallner, F; De Martino, BM; Riccardi, F; Maione, A; Eisenwagen, S; Vitale, G; Cartenì, G (In this study, 120 patients were randomly divided into 2 groups. One group received a preparation containing zeolite, and the other group received a placebo. The occurrence and severity of peripheral neuropathy due to oxaliplatin chemotherapy were measured. After 6 months, no differences in occurrence or severity were found between the groups. Further analyses seem to find an advantage only for men, but this result must be critically viewed due to the lack of information and the failure to co...)
• 12:11, 8 July 2024 JDoerfler talk contribs created page Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Reference |Reference=Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial }} {{Study Note}} =Brief summary= This study investigated the effectiveness of vitamin E in preventing chemotherapy-induced peripheral polyneuropathy. The vitamin E arm took vitamin E twice a day in parallel with chemotherapy until one month after chemotherapy, while the control arm received only a place...")
• 11:46, 8 July 2024 JDoerfler talk contribs created page Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Publication |Title=The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial |Topic=Vitamin E |Author=Kottschade, LA; Sloan, JA; Mazurczak, MA; Johnson, DB; Murphy, BP; Rowland, KM; Smith, DA; Berg, AR; Stella, PJ; Loprinzi, CL |Year=2011 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-010-1018-3 |Authors Abstract=Background: Chemotherapy-induced peripheral neuropathy (CIPN) co...")
• 05:15, 8 July 2024 MKraft talk contribs created page Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial (Created page with "{{Reference |Reference=Publication: Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial }} {{Study Note |Study Note=? }} =Brief summary= The study included 81 patients with different types of cancer and a history of nausea and vomiting due to chemotherapy. They were randomly divided into 2 groups, one group received THC and CBD daily and the other group a placebo. After one cycl...")
• 04:59, 8 July 2024 MKraft talk contribs created page Publication: Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial (Created page with "{{Publication |Title=Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial |Topic=Cannabinoids |Author=Grimison, P; Mersiades, A; Kirby, A; Lintzeris, N; Morton, R; Haber, P; Olver, I; Walsh, A; McGregor, I; Cheung, Y; Tognela, A; Hahn, C; Briscoe, K; Aghmesheh, M; Fox, P; Abdi, E; Clarke, S; Della-Fiorentina, S; Shannon, J; Gedye, C; Begbie, S; Simes, J; Stockler, M |Year=2020 |J...")
• 12:07, 6 July 2024 EProba talk contribs created page Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects (Created page with "{{Reference |Reference=Publication: Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects }} {{Study Note |Study Note=? }} =Brief summary= 120 women with cervical cancer were included in this study. All patients received the same radiotherapy. One group of 60 people also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin), which was taken during the radiotherapy. Ano...")
• 11:26, 6 July 2024 EProba talk contribs created page Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. (Created page with "{{Author}}")
• 11:25, 6 July 2024 EProba talk contribs created page Publication: Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects (Created page with "{{Publication |Title=Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects |Topic=Enzymes (bromelain papain) |Author=Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. |Year=2001 |Journal=Cancer Chemotherapy and Pharmacology |DOI=https://doi.org/10.1007/s002800170006 |Authors Abstract=Purpose: The use of additional therapy with an oral enzyme preparation containing trypsin, chymotrypsin and pa...")
• 13:50, 5 July 2024 JDoerfler talk contribs created page Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Reference |Reference=Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation }} {{Study Note}} =Brief summary= In this study, various leukemia patients were divided into two different arms prior to bone marrow transplantation. One arm began taking vitamin E seven days before the operation until 28 days afterwards in addition to chemotherapy, while the other received only a placebo in...")
• 13:48, 5 July 2024 JDoerfler talk contribs created page Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Publication |Title=Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation |Topic=Vitamin E |Author=Ghoreishi, Z; Shidfar, F; Iravani, M; Esfahani, A; Ghavamzadeh, A |Year=2007 |Journal=Asia-Pacific Journal of Clinical Oncology |DOI=https://10.1111/j.1743-7563.2007.00111.x |Authors Abstract=Aim: This study was conducted to investigate the effect of oral vitamin E on mucositis and neutropenia in p...")
• 12:34, 5 July 2024 JDoerfler talk contribs created page Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Reference |Reference=Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were divided into two different arms before radiotherapy. One arm received additional vitamin E throughout the radiotherapy and the other arm only a placebo. There were significantly fewer cases of oral mucositis (i.e. inflammation...")
• 12:10, 5 July 2024 JDoerfler talk contribs created page Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Publication |Title=Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial |Topic=Vitamin E |Author=Ferreira, PR; Fleck, JF; Diehl, A; Barletta, D; Braga-Filho, A; Barletta, A; Ilha, L |Year=2004 |Journal=Head and Neck |DOI=https://10.1002/hed.10382 |Authors Abstract=Abstract: Background. The study was designed to test whether vitamin E (VE) provides oral mucosal protection in patients with irradiated c...")
• 11:29, 5 July 2024 JDoerfler talk contribs created page Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Reference |Reference=Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on an...")
• 11:21, 5 July 2024 JDoerfler talk contribs created page Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Publication |Title=Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? |Topic=Vitamin E |Author=Fallahi, B; Beiki, D; Abedi, SM; Saghari, M; Fard-Esfahani, A; Akhzari, F; Mokarami, B; Eftekhari, M |Year=2013 |Journal=Nuclear medicine communications |DOI=https://10.1097/MNM.0b013e328362b1f2 |Authors Abstract=Objectives Salivary gland impairment after high-dose radioiodine (131I) treatment is well recognized. The aim of thi...")
• 10:17, 5 July 2024 CHoppe talk contribs created page Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Created page with "{{Reference |Reference=Publication: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma }} {{Study Note |Study Note=In this study, two groups of neck and head tumor patients were compared with regard to the progression-free interval. One group received vitamin D for 3 weeks before the tumor operation and the other group received nothing. In the vitamin D group, it took significantly longer for the dise...")
• 10:16, 5 July 2024 CHoppe talk contribs created page Publication: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Created page with "{{Publication |Title=Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma |Topic=Vitamin D |Author=Walsh, JE; Clark A-M; Day, TA; Gillespie, MB; Young, MRI |Year=2010 |Journal=Human immunology |DOI=10.1016/j.humimm.2010.04.008 |Authors Abstract=Prior studies have shown that treatment of head and neck squamous cell carcinoma (HNSCC) patients with 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] reduced...")
• 09:22, 5 July 2024 JDoerfler talk contribs created page Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Reference |Reference=Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-9...")
• 09:21, 5 July 2024 JDoerfler talk contribs created page Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Publication |Title=Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis |Topic=Vitamin E |Author=Delanian, S; Porcher, R; Balla-Mekias, S; Lefaix, J-L |Year=2003 |Journal=Journal of clinical Oncology |DOI=https://10.1200/JCO.2003.06.064 |Authors Abstract=Purpose: Radiation-induced fibrosis (RIF) is a rare morbid complication of radiotherapy, without an established method of management. R...")
• 14:27, 4 July 2024 JDoerfler talk contribs created page Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Reference |Reference=Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries o...")
• 14:26, 4 July 2024 JDoerfler talk contribs created page Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Publication |Title=Prospective evaluation of vitamin E for hot flashes in breast cancer survivors |Topic=Vitamin E |Author=Barton, DL; Loprinzi, CL; Quella, SK; Sloan, JA; Veeder, MH; Egner, JR; Fidler, P; Stella, PJ; Swan, DK; Vaught, NL; Novotny, P |Year=1998 |Journal=Journal of clinical Oncology |DOI=https://doi.org/10.1200/JCO.1998.16.2.495 |Authors Abstract=Purpose Hot flashes are a significant issue for many breast cancer survivors, with concerns over the use of...")